Medlay Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
- Revenue Growth 11.13%
- Profit Growth 61.98%
- Ebitda 61.04%
- Net Worth 6.12%
- Total Assets 5.87%
About Medlay Healthcare
Medlay Healthcare Private Limited (MHPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 February 2013 and has a history of 11 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹4.50 M.
Bimal Narain, Vipin Nasa, and Seema Nasa serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2013PTC248604
-
Company No.
248604
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Feb 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Medlay Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bimal Narain
|
Director | 02-Jul-2018 | Current |
|
Vipin Nasa
|
Director | 20-Feb-2013 | Current |
|
Seema Nasa
|
Director | 20-Feb-2013 | Current |
Financial Performance of Medlay Healthcare.
Medlay Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.13% increase. The company also saw a substantial improvement in profitability, with a 61.98% increase in profit. The company's net worth moved up by a moderate rise of 6.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medlay Healthcare?
Unlock access to Medlay Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Luvya Medicare Private LimitedVipin Nasa and Seema Nasa are mutual person
-
Sarv Lifesciences Private LimitedSeema Nasa is a mutual person
Charges (Loans)
₹0.45 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2017 | Others | ₹4.50 M | Open |
How Many Employees Work at Medlay Healthcare?
Unlock and access historical data on people associated with Medlay Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medlay Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medlay Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.